Sort
30,917 grants matching “tumor microenvironment”
Markers of Susceptibility as Predictors of Blasser Cancer Recurrence
$262,931Xifeng Wu · University Of Tx Md Anderson Can Ctr · P50 · FY2009 · CA
Therapeutic anti-angiogenesis and tumor microenvironment
$262,921Timothy F Lane · University Of California Los Angeles · R01 · FY2009 · CA
Therapeutic anti-angiogenesis and tumor microenvironment
$262,921Timothy F Lane · University Of California Los Angeles · R01 · FY2008 · CA
Therapeutic anti-angiogenesis and tumor microenvironment
$262,921Timothy F Lane · University Of California Los Angeles · R01 · FY2007 · CA
The role of gut microbe-derived choline metabolites in driving the pro-inflammatory macrophage phenotype and restricting pancreatic cancer
$262,871Rahul Suresh Shinde · Wistar Institute · R21 · FY2021 · CA
HOW ENVIRONMENTAL CHEMICALS IMPAIR IMMUNITY
$262,847Boston University Medical Campus · R01 · FY2002 · ES
Clinical significance and mechanism of action of exosomal microRNAs in Neuroblastoma chemoresistance.
$262,816Muller Fabbri · University Of Hawaii At Manoa · R01 · FY2018 · CA
Altering Post Vaccination T Cell Contraction
$262,800Medical University Of South Carolina · R01 · FY2004 · CA
Altering Post Vaccination T Cell Contraction
$262,800Medical University Of South Carolina · R01 · FY2005 · CA
Project 4 Treatment of Advanced Ovarian Cancer Using Gene-Edited NK CAR Cells
$262,688Branden S Moriarity · Mayo Clinic Rochester · P50 · FY2021 · CA
Exploiting Therapeutic Vulnerabilities
$262,672William A Weiss · Children'S Hospital Of Los Angeles · P01 · FY2019 · CA
Determining Molecular Mechanisms of NSCLC and Response to beta-glucan
$262,672Andrew N Lane · University Of Kentucky · P01 · FY2015 · CA
Role of elF2a phosphorylation and ER stress in hypoxia tolerance and tumor growth
$262,604Constantinos Koumenis · University Of Pennsylvania · R01 · FY2013 · CA
Investigating mechanisms of oxidized phospholipid-mediated dysregulation of regulatory T cells in atherosclerosis
$262,500Amy S Major · Vanderbilt University Medical Center · R21 · FY2023 · AI
Microenvironment determinants of radio-sensitivity in human high grade glioma
$262,500Christopher Paul Cifarelli · West Virginia University · P20 · FY2019 · GM
The importance of viral and host circular non-coding RNAs in human papillomavirus-related cancers
$262,500Ivan Martinez · West Virginia University · P20 · FY2018 · GM
Utilizing interleukin-15 to target tumor microenvironment and muscle fatigue during cancer
$262,499Emidio Edward Pistilli · West Virginia University · P20 · FY2018 · GM
Utilizing interleukin-15 to target tumor microenvironment and muscle fatigue during cancer
$262,499Emidio Edward Pistilli · West Virginia University · P20 · FY2019 · GM
Chemokine Signals in Head and Neck Cancer Progression
$262,486Robert L Ferris · University Of Pittsburgh At Pittsburgh · R01 · FY2006 · CA
Phase 1 study to test safety and dose of proglumide as an anti-fibrotic agent
$262,453Jill P Smith · Georgetown University · R21 · FY2020 · CA
(PQ8) Predictive biomarkers for the onset of immune-related adverse events associated with PD-1 blockade
$262,440Adam Mor · Columbia University Health Sciences · R21 · FY2019 · CA
Project 1: Combinatorial adjuvants promote uniform and selective intratumoral CTL infiltration in colorectal cancer
$262,423Pawel Kalinski · Roswell Park Cancer Institute Corp · P01 · FY2024 · CA
Perioperative Stromal Depletion Strategies in Pancreatic Ductal Adenocarcinoma
$262,418Margaret A Tempero · University Of California, San Francisco · R21 · FY2014 · CA
VSV INFECTION OF THE CENTRAL NERVOUS SYSTEM
$262,414New York University · R01 · FY2003 · DC
Impact of pre-existing T cell memory on oncolytic virus therapy
$262,400Pamela Rosato · Dartmouth College · P20 · FY2021 · GM